Thermo Fisher Scientific Inc. has announced an expansion of their strategic partnership with Sanofi to enable additional...
Onsite coverage by Hithaishi Bhaskar CPHI & PMEC China 2025 has emerged as a cornerstone of the global pharmaceutic...
365mc, South Korea's leading medical institution specialising in fat reduction treatments, and Israel-based Ra...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of India-based Biocon Ltd. has ...
In the newly released "Paediatric drug optimisation for respiratory syncytial virus (PADO-RSV) meeting report" by Global...
Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...
Onsite Coverage by Hithaishi Bhaskar CPHI & PMEC China 2025 redefined China's pharmaceutical landscape, offering un...
A significant advancement in weight management has arrived for Singaporeans. Novo Nordisk, a global healthcare company f...
South Korea-based biopharmaceutical company Samsung Bioepis has published a whitepaper titled ‘Solving the Biosimi...
DKSH Business Unit Healthcare, a Strategic Healthcare Solutions Partner and leading provider of Market Expansion Service...
Japan's JCR Pharmaceuticals Co. has entered into a license agreement with Alexion, AstraZeneca Rare Disease, for JCR&rsq...
China-based CStone Pharmaceuticals has announced an exclusive partnership with Istituto Gentili, a leading European biop...
Health2Sync, Asia's leading digital chronic disease management platform, has announced the successful integration of Sma...
Celltrion has announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimila...
Japan's Chugai Pharmaceutical and Gero, a Singapore-based biotechnology company, have entered into a joint research...
BioVersys AG, a multi-asset, clinical stage biopharmaceutical company based in Switzerland, focusing on research an...
Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across disea...
BioSpectrum Asia spoke to Dr Peter Fedichev, CEO of Gero, who explains how ProtoBind-Diff is transforming drug discovery...
What if a key part of the solution to Asia’s looming demographic crisis lies in embracing something we in the phar...
What major initiatives are lined up for Asahi's healthcare business in 2025 and beyond? Are you planning any major inves...
It’s universally acknowledged that Asia-Pacific (APAC) is a hotbed for clinical trials, with multiple reports conf...
Neurizon Therapeutics, a clinical-stage biotech company based in Australia, has announced the development of a new oral ...
Innovent Biologics, Inc. has announced that China's National Medical Products Administration (NMPA) has approved mazduti...
South Korea-based SK Biopharm has signed a strategic Memorandum of Understanding (MoU) with AI corporation PhnyX Lab in ...
Bayer and Tsinghua University (THU) have announced the signing of the sixth phase of the collaboration agreement, aiming...
